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Background: Emerging evidence indicates that dysregulated long intervening non-coding RNA (lincRNA) HOTAIR
correlates highly with tumor invasion and metastasis but a link between the high expression of HOTAIR and the
metastatic cascade of cancer stem cells (CSCs) needs to be further studied. The purpose of this study was to
investigate the effect of down-regulated HOTAIR expression on tumorgeniesis and metastasis of epithelial ovarian cancer
(EOC) CSCs. CD117+CD44+CSCs were isolated from human EOC SKOV3 cell line by using a magnetic-activated cell sorting
system, and were then transfected with the expression vector-based small hairpin RNA targeting HOTAIR; the
stably transfected cells were selected for the study. Colony-forming, wound-healing, cellular metastasis and tumorigenicity
assays were performed.
Results: The results demonstrated that the HOTAIR expression in clinical EOC tissues and SKOV3 CD117+CD44+CSCs
was higher than in SKOV3 tumor tissues and non-CD117+CD44+CSCs. The CD117+CD44+-shHOTAIR showed an
inhibited HOTAIR expression, reduced cell migration and invasion than CD117+CD44+- scramble, suggesting the
inhibition of an epithelial-mesenchymal transition. Moreover, the downregulated HOTAIR expression in CD117
+CD44+ CSCs significantly decreased the tumor growth and lung metastasis in xenograft mice.
Conclusion: Our findings demonstrated the shHOTAIR-mediated down-regulation of the HOTAIR expression in
CD117+CD44+ CSCs can be a promising new opportunity for future clinical trials.
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interferenceIntroduction
Human epithelial ovarian cancer (EOC) is one of malig-
nant tumors in gynecological cancers and currently
remains to be the number one the first leading cause of
cancer-related deaths in women due to factors such as
failure for its early dectection and diagnosis, its proneness
to pelvic and peritoneal metastasis, and its resistance to* Correspondence: njwjdj@sina.com; njdoujun@seu.edu.cn
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unless otherwise stated.chemotherapy after recurrence. Although many studies
have been published in the past decade and have contrib-
uted to the advance of the knowledge in this field, the com-
plex biology of EOC is still insufficiently understood [1,2].
Therefore, more recent studies have focused on the mo-
lecular mechanisms underlying the EOC progression and
the new strategies for early clinical diagnosis and effective
therapy [3,4].
Recent studies have demonstrated that cancer stem cells
(CSCs) are responsible for tumour-initiating potential, me-
tastasis and eventual relapse. Thus, the treatments that
target CSCs may lead to the discovery of effective methods
to eradicate the malignant tumor cells [5-7].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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non-coding RNAs (lincRNAs) play a critical role in regu-
lating cellular processes such as differentiation, prolifera-
tion, and metastasis [8,9]. HOX transcript antisense RNA
(termed HOTAIR), one of lincRNAs, functions in epigen-
etic regulatory processes, interacts with polycomb repres-
sive complex 2 and is required for histone H3 lysine-27
trimethylation of the HOD locus. In addtion, HOTAIR has
been strongly associated with the invasion and metastasis
of cancer cells [10]. Dysregulation of lncRNA HOTAIR
has been considered a primary feature of several human
cancers including breast cancer [10,11], hepatocellular
carcinoma [12,13], colorectal cancer [14], pancreatic carcin-
omas [15], gastrointestinal stromal tumors [16], and human
EOC [17,18]. Of the many functions of HOTAIR, as tumor
regulatory factors, the one for silencing HOTAIR transcrip-
tion in CSCs has remained insufficiently understood
[17,19]. For this reason, we investigated whether the down-
regulated HOTAIR expression would decrease the human
EOC SKOV3 CD117+CD44+CSC metastasis by inhibiting
epithelial- mesenchymal transition (EMT) in vitro, as well
as cellular tumorigenicity in nude mice. The data from our
current study showed that epigenetic silencing of lncRNA
HOTAIR in SKOV3 CD117+CD44+CSCs resulted in re-
duced cellular tumorgeniesis and metastasis in mouse
model. This fingings suggested that the streatgy of down-
regulating the HOTAIR expression may serve as a potential
anti-cancer regimen for inhibiting EOC CSC’s invasiveness




SKOV3 cell line was acquired from an ovarian cancer
patient, which is a well-established ovarian cancer model
system; the line was purchased from the Cellular Insti-
tute in Shanghai, China. Cells were cultured in complete
media consisting of RPMI 1640, 2 mM L-glutamine, 100
U/ml penicillin, 100 μg/ml streptomycin, and 10% fetal
bovine serum. The medium was refreshed every 3 days
to maintain adherent cells. When the SKOV3 cells
reached 90% confluence, cells were harvested with 0.25%
trypsin −1 mM EDTA (Sigma-Aldrich, St. Louis, MO,
USA) treatment for 2 min.
Isolation of CD44+CD117+cells and identification of cell
phenotype
CD44+CD117+cells were sorted from the SKOV-3 cell
line by using the magnetic-activated cell sorting (MACS,
Miltenyi Biotec., Bergisch Gladbach, Germany). First,
CD44+subsets were isolated by using the mouse antihu-
man CD44 antibody coupled to magnetic microbeads (code
number:130-095-194, antibody dilution,1:20, Miltenyi
Biotec., Bergisch Gladbach, Germany) and followed bythe magnetic column selection or depletion. Second,
the resulting cells were then depleted of CD117−subsets
by using mouse antihuman CD117 antibody coupled to
magnetic microbeads (code number:130-091-332, anti-
body dilution,1:20, Miltenyi Biotec., Bergisch Gladbach,
Germany), and we named the CD44+CD117+cells for
the EOC cancer stem cells as ‘EOC SKOV-3 CD44
+CD117+CSCs’ [20-22]. The isolated cells were placed
in stem cell culture medium by resuspension in serum-
free DMEM/F12 supplemented with 5 μg/mL insulin
(Sigma-Aldrich, Missouri, USA), 20 ng/mL human re-
combinant epidermal growth factor (Invitrogen, CA, USA),
10 ng/mL basic fibroblast growth factor (Invitrogen, CA,
USA) and 0.5% bovine serum albumin (Sigma-Aldrich,
Missouri, USA) [23,24]. The isolated CD44+CD117+cells
were further identified by using flow cytometer (FCM, BD,
USA) [25].
The short hairpin RNA sequence design
A short hairpin RNA sequence of lncRNA HOTAIR was de-
signed based on the HOTAIR RNA sequence (Gene ID:
100124700) by using the siDESIGN design software (Dhar-
macon, http://www. thermoscientificbio.com/design-center/)
and the Block-iTTM RNAi Designer (Invitrogen, Grand
island, NY) as well as BLAST (http:// www. ncbi. nlm.nih.
gov/BLAST). The target sequence site for HOTAIR shRNA
includes 19 base pairs of the HOTAIR RNA sequence.
In addition, one scramble sequence was designed as a nega-
tive control. The shRNA sequences are as follows: pSUPER-
EGFP1-HOTAIR-shRNA (pSUPER- EGFP1-shHOTAIR),
Forward 5′-GATCCCCGAACGGGAGTACAGAGAGATT
CAAGAG A TCTCTC TGTACTCCCGTTCTTTTTGGA
AA-3′; antisense,5′-AGCTTTTCCAAAAAGAACGGG A
GTACAGAGAGATCTCTTGAATCTCTCTGTACTCCCG
TTCGGG-3′;scramble-siRNA: sense, 5′- GATCCCCTTC
TCCGAACGTGTCACGTTTCAAGAGAACGTGACACG
TTCGGAGA ATTTTTGG A AA-3′; antisense, 5′-AGCT
TTTCCAAAATTCTCCGAACGTGTCACGT-TCTCTTG
AAACGTGAC ACGTTCGGAGAAGGG-3′. All the primers
were synthesized by Gene and Technology of China in
Shanghai [10].
Construction of pSUPER-EGFP1-HOTAIR -shRNA and
production of stably transfected clones
A pSUPER-EGFP1 (enhanced green fluorescent protein 1)
vector was used to construct recombinant. The recombin-
ant pSUPER-EGFP1-HOTAIR-shRNA (shHOTAIR) was
developed as previously describled [10,26]. A pSUPER-
EGFP1-scrambled shRNA (Scramble-HOTAIR) was used
as a negative control. These recombinants were verified by
the analysis of endonuclease digestion and sequencing. The
shHOTAIR and SCHOTAIR were respectively transfected
into CD44+CD117+CSCs and the stably transfected clones
were selected with G418 (Clontech, CA). ShHOTAIR-
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labeled ‘CD44+CD117+ shHOTAIR’and ‘CD44+CD117+
scramble’, respectively.Clinical samples
Four fresh surgical tissue samples of EOC patients with
a median age of 55 years (age range 45–63) were col-
lected at the Department of Gynecology & Obstetrics,
Zhongda Hospital, Medical School, Southeast University
between March 2012 and October 2012. The four surgi-
cal tumor samples used in this study (designated T1-T5)
were categorized as malignant Fesddration Internation-
ale des Gynaecologistes et Obstetristes (FIGO) stage II-
III serous adenocarcinomas. All samples were stored im-
mediately in liquid nitrogen until analysis [21].Quantitative RT-PCR of HOTAIR
Total RNA was extracted from the SKOV-3 CD44+CD
117+CSCs or SKOV-3 cells or microdissected tumor tissue
samples of EOC patients by using a Qiagen RNeasy Kit
(Qiagen, Valencia, CA, USA) following by the manufac-
turer’s protocol. A single-stranded cDNA was prepared by
the using SuperScript III reverse transcriptase (Invitrogen).
Quantitative real-time reverse transcription-PCR (qRT-
PCR) was carried out on an ABI step one plus real-time
system (Applied Biosystems, USA). The cDNAs were
amplified by PCR with primers as follows: HOTAIR:
sense, 5′-GGTAGAAAAAGCAACCACG AAGC-3′; anti-
sense, 5′-TTGGGGAAGCA TTTT CTGAC-3′; β-actin
(sense, 5′-GGACTTCGAG CAAG AGATGG-3′; antisense,
5′-AGCACTGT GTTGGCGTACAG-3′). U6-RT Primer,
5′-GTCGTATCCAG TGCAGGGTCCGAGGTATTCGCA
CTGGATACGACAAATATGGAAC-3′; sense, 5′-TGCGG





GTCTCCGGTACTCA. The mRNA levels of the genes of
interest were expressed as the ratio of each gene of inter-
est to β-actin or U6 mRNA for each sample. The com-
parative Ct (ΔΔCt) method was used to determine the
expression fold change [27,28].Colony forming assay
The colony formation ability of SKOV3 CD117+CD
44+-shHOTAIR was investigated. A colony with a
diameter larger than 75 μm or having more than 50
cells was counted for 1 positive colony according to
our previous report [20]. The plate clone formation ef-
ficiency was calculated as (number of colony/number
of cells inoculated) × 100%.Cell migration assay
To determine the role of down-regulated HOTAIR expres-
sion on migration, SKOV3 CD117+CD44+- shHOTAIR were
used in the wound healing assay. Briefly, SKOV3 CD117+
CD44+-shHOTAIR or SKOV3CD117+CD44+-scramble were
plated in 6-well plates (5 × 105 cells per well) to form a
monolayer one day before the assay; non-adherent cells were
removed by PBS washing. On the following day, a uniform
scratch was made down in the center of the well using a
sterile micropipette tip. The distance travelled by the cells
was measured between the two boundaries of the acellular
area at 0, 24, 48 and 96 hours respectively, after incubation.
Each experiment was performed in triplicate [29].
Cell invasion assay
The invasion ability of SKOV3 CD117+CD44+-shHOTAIR
or SKOV3 CD117+CD44+-scramble was evaluated by using
the transwell invasion assay as previously described [30].
Briefly, the transwell inserts with 8 μm pores were coated
with Matrigel (20 μg/well; Becton Dickinson, Waltham,
MA, USA); cells were seeded in the upper chamber in
RPMI1640 medium supplemented with 10% fetal bovine
serum. After incubation at 37°C, the cells that invaded to
the lower surface of the Matrigel-coated membranes were
fixed with 70% ethanol and stained with trypan blue; the
cells from five randomly selected fields were then counted
under a light microscope.
Western blotting analysis
Approximately 1 × 106 SKOV3 CD117+CD44+-shHO-
TAIR or SKOV3CD117+CD44+-scramble were collected
and lyzed in the protein extraction buffer (Novagen,
Madison, WI, USA), and 12% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis was performed and
proteins (10 μg/lane) were loaded by following the
pulished papers [6,31]. The rabbit antibody specific to
human E-cadherin (code number: 31955) or Vimentin
(code number: 57415) was used in the assay (Bioworld
Technology, Dublin, OH, USA). The antibody dilution
was 1: 1000.
Tumorigenicity of shHOTAIR-SKOV3 CD117+CD44+ CSCs
in an xenograft mice
Balb/c nude mice (female, weight: 16-18 g and age between
5 and 6 weeks) were ordered from the Animal Center of
Yang Zhou University of China and were raised under ster-
ile conditions at the Experimental Animal Center, Medical
School of Southeast University. The experiments were per-
formed in compliance with the guidelines of the Animal
Research Ethics Board of Southeast University, China.
Twelve nude mice were randomly divided into two groups
of equal size (six per group): the SKOV3 CD117+CD44+-
shHOTAIR group, and the SKOV3CD117+CD44+-scram-
ble group. The nude mice was subcutaneously injected in
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or SKOV3 CD117+CD44+-scramble. Tumor formations in
each mouse were monitored every three days by taking 2-
dimensional measurements of individual tumors from
each mouse [32].
Lung histopathology
Lung tissues were removed from the xenograft mice,
fixed in 10% formalin, and then embedded in paraffin.
Lung tissue sections of 4μm thin were cut and mounted
on SuperFrost Plus glass slides; the tissues were fixed in
methanol and stained in hematoxylin and eosin (HE).
The slides were viewed under a Zeiss Axioplan light
microscope at a magnification of × 200 [33].
Statistical analysis
Values of interest were presented as the mean plus or
minus two standard deviation. Statistical comparisons
were performed using the Student’s t-test method. ResultsFigure 1 Detection of HOTAIR expression in tumor tissues and CD117+
expression in four patient’s EOC tissues and six SKOV3 tumor tissues in the m
sorted from the SKOV-3 cells by using the magnetic-activated cell sorting syst
and 3.1%, respectively, of the double positive phenotypes of CD44 and CD11
expression in both the CD117+CD44+ cells and the non CD117+CD44+ cells. *
t test method, referring to the differences as indicated.for all analyses with a P value < 0.05 indicate the statisti-
cally significant differences.
Results
HOTAIR expression in EOC tissues and SKOV3
CD117+CD44+ CSCs
In this study, we first wanted to know whether the HOTAIR
expression existed in human EOC tissues and in tumor bear-
ing mice injected with SKOV3 cells. The result of qRT-PCR
in Figure 1A shows that the HOTAIR expression not only
existed in the EOC patient’s tumor tissues but its expression
was significantly increased compared with SKOV3 tumor
tissues in nude mice (p < 0.001). Next, we further investi-
gated whether the HOTAIR expression was increased in
SKOV3 CD117+CD44+CSCs compared with SKOV3 non-
CD117+ CD44+CSCs in order to find a novel thera-
peutic target for theatment of EOC. As Figure 1B por-
trays, the CD117+CD44+cells, termed CD117+CD44+CSCs
as described in our previous reports [6,22], were isolated byCD44+CSCs identified by qRT-PCR and FCM. A. The HOTAIR
ice tested by qRT-PCR. B and C. The cell phenotype of CD44+CD117+cells
em (B) and the SKOV-3 cells (C) were analyzed by FCM, indicating 92.3%
7 in sorted cells and SKOV-3 cells. D. QRT-PCR analysis of the HOTAIR
*p < 0.01 and ***p < 0.001 were calculated by using the Student’s
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cells reached 92.3%, but there were only 3.1% of CD117+
CD44+cells in SKOV3 cells (Figure 1C). Figure 1D shows
the high expression of HOTAIR in CD117+CD44+CSCs in
contrast with non-CD117+ CD44+ CSCs (p < 0.01).
Effects of down-regulated HOTAIR in SKOV3 cells on the
ability of migration and invasion
Since HOTAIR plays important regulatory roles in the
malignant tumor progression through regulating cell
cycle, apoptosis, invasion and metastasis, a high expres-
sion of HOTAIR correlates highly with some epithelial
tumor metastasis and invasion [10,11]. Therefore, we
investigated whether this correlation was changed whenFigure 2 HOTAIR-shRNA SKOV3 cells decreased the ability of cell mig
SKOV3 cells were respectively subjected to qRT-PCR and Western blot assay
Vimentin (C, D) in the SKOV3 cells transfected with siHOTAIR or siCONTAL
respectively plated in 6-well plates to form a monolayer, and on the follo
using a sterile micropipette tip. Wound closure (light microscopy, ×200) i
F. Quantification of the wound healing assay result. G. The invasive assay
upper chamber in RPMI1640 with serum-free. Cells that invaded to the lo
for 48 h, next fixed with 70% ethanol, and finally stained with trypan blue
microscope (magnification ×100). H. Quantification of the invasive assay
as indicated.the HOTAIR expression was down-regulated in the
SKOV3 cells. According to the previous report [10],
we synthesized siHOTAIR 5′-GAACGGGAGUACAGA
GAGAUU-3′ that was transfected into the SKOV3
cells. Indeed, the HOTAIR expression was markedly
decreased compared with the SKOV3 cells (p < 0.05)
24 hours after the cells were transfected with siHO-
TAIR 50 nanomolar (Figure 2A). This efficacy led to the
observations that the E-cadherin expression (epithelium
features) was obviously increased and the Vimentin ex-
pression (mesenchymal features) was markedly decreased
(Figure 2B-D). In addition, Figure 2E and G show that
the migration and invasion ability of the SKOV3 cells was
also remarkablely decreased compared with the SKOV3ration and invasion. A-D. RNA and proteion extracts from 1 × 106
s for detection of the expression of HOTAIR (A) E-cadherin (B, D) and
(scramble). E. In vitro wound healing, 5 × 105 different cells were
wing day, a uniform scratch was made down in the center of well
s presented the percentage reduction of the freshly wounded area.
result shows that 5 × 105 different SKOV3 cells were seeded in the
wer surface of the Matrigel-coated membranes after being incubatied
. Cells from five randomly selected fields were counted under a light
result. * P < 0.05 and **P < 0.01, referring to the differences
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Figure 2E-H (p < 0.05 or p < 0.01).
Effect of down-regulated HOTAIR in CD117+CD44+ CSCs
on the ability of colony, migration and invasion
To stably reduce the HOTAIR expression, we next devel-
oped the recombinant shHOTAIR to investigate the effect
of down-regulated HOTAIR expression on the ability of col-
ony, migration and invasion in SKOV3 CD117+CD44+ CSCs
in vitro. The validated CD117+CD44+CSCs by FCM were
transfected with the recombinant shHOTAIR (Figure 3A,
right-panel) or scrambled HOTAIR (Figure 3A, left-panel),
which were observed under a fluorescence microscope (top-
panel) and under a light microscope (bottom-panel). The
stably transfected CD117+CD44+-shHOTAIR decreased the
HOTAIR expression by 54 ± 5% (Figure 3B) and reduced its
colony forming rate (18 ± 6%) compared with the CD117+
CD44+ scramble (46 ± 7%, Figure 3C); the differences were
statistically significant (p < 0.01, Figure 3B and D). Figure 4A
exhibits the image of the cell migration results tested by the
wound healing assay. Cell migration rates at 24 and 48 hours
showed a statistically significant reduction in CD117+CD44+
-shHOTAIR compared with CD117+CD44+-scramble in theFigure 3 CD117+CD44+-shHOTAIR reduced the HOTAIR expression an
the recombinant shHOTAIR or scramble HOTAIR were selected by 800 μg/ml
fluorescence microscope (top) and from a light microscope (bottom). B. QRT-
and CD117+CD44+-scramble. C. Images of CD117+CD44+- shHOTAIR and CD1
colony forming ratio. **P < 0.01.wound closures, particularly at 48 hours (p < 0.01,
Figure 4A and B). In addtion, the effect of silencing
HOTAIR on the invasive ability of CD117+CD44+-shHO-
TAIR was further evaluated by the transwell invasive
assay. Figure 4C indicats the representative images of the
cell invasion, which showed a marked decreased in CD117
+CD44+-shHOTAIR compared with those transfected with
CD117+CD44+-scramble (Figure 4D, p < 0.01).
Down-regulated HOTAIR in CD117+CD44+CSCs inhibited
the tumor growth and metastasis in the xenograft mouse
model
After observing the effects of the down-regulated HOTAIR
expression on the migration and invasion of SKOV3 CD117
+CD44+-shHOTAIR in vitro, we further tested whether this
effect would alter the tumorigenicity and metastatic poten-
tial of CD117+CD44+-shHOTAIR in the Balb/c nude mice.
Figure 5A shows the representative images on day 24 after
implantation; all the 6 mice generated tumors in 20 days
after being injected with 5 × 104 SKOV3 CD117+CD44+
-scramble. The injected mice developed a visible tumor on
Day 12, Day 14, Day 16, Day 18, Day 19, and Day 20, re-
spectively. In contrast, 5 of the 6 mice injected with thed colony forming potential. A. CD117+CD44+ CSCs transfected with
G 418 in two weeks (magnification 200×). Images were taken from a
PCR analysis of the HOTAIR expression in both CD117+CD44+-shHOTAIR
17+CD44+-scramble in colony forming assay. D. Statistical analysis of
Figure 4 CD117+CD44+-shHOTAIR reduced its migration and invasion potential in vitro. Images of cell migration assay results (A) and cell
invasion assay result (C). The methods are described as in Figure 2. B. Quantification of the metastatic assay results. D. Quantification of the
invasive assay result. * P < 0.05 and **P < 0.01, referring to the differences as indicated.
Wang et al. Cancer Cell International  (2015) 15:24 Page 7 of 105 × 104 SKOV3 CD117+CD44+-shHOTAIR developed vis-
ible tumors on Day 14, Day 16, Day 18, Day 26, and Day
26, respectively, and the remaining 1 mouse did not de-
velop tumor throughout the 64-day observation period.
Figure 5B presents the percentages of the tumor-free mice
in the two groups. Figure 5C exhibits the images of the
tumor size and quantity. Tumor growth was significantly
inhibited in the mice injected with the CD117+CD44+
-shHOTAIR compared with the mice injected with the
CD117+CD44+-scramble, and the tumor volume was sig-
nificantly reduced in the former (p<0.01) (Figure 5D).
To assess the effect of the down-regulation of HOTAIR
in CD117+CD44+-shHOTAIR on tumor metastasis, we
used H&E staining to detect if there was tumor cell metas-
tasis in the lung tissues. Compared with the mice injected
with CD117+CD44+-scramble, no tumor cell metastasis
was found in the lung tissues of the nude mice 64 days
after they were injected with the CD117+CD44+-shHO-
TAIR (Figure 5E). It is thus evident from the results that
the tumor cell growth and metastasis were significantly
inhibited in the mice injected with CD117+CD44+-shHO-
TAIR compared with the mice injected with CD117+
CD44+-scramble.Discussion
EOC is the most lethal gynecological malignancy in the
world and approximately 30% of cancer patients have
died this disease; this emphasizes the need for improved
early detection and effective treatment [34]. Evidence
has indicated that CSCs are believed to be the ‘seed cell’
in cancer recurrences and metastases, however, treatments
targeted at CSCs have remained to be developed and stud-
ied [35]. Increasing evidence supports that CSCs possess
mesenchymal characteristics and EMTability, and that the
decreased change in lincRNA HOTAIR was associated
with alterations in specific EMT markers concurrent with
reduced migratory potential [6,10,36]. In this regard, our
current study was designed to investigate whether human
EOC tissues and SKOV3 CD117+CD44+CSCs expresse
HOTAIR and whether the decreased change of HOTAIR
in human EOC SKOV3 CD117+CD44+CSCs are closely
associated with the tumorgeniesis and metastasis. Indeed,
our data indicated that human EOC patients’ tumor tis-
sues and SKOV3 CD117+CD44+ CSCs had significantly
high expressions of HOTAIR compared with the SKOV3
tumor tissues and SKOV3 non-CD117+CD44+CSCs, and
that the down-regulated HOTAIR expression in CD117
Figure 5 CD117+CD44+-shHOTAIR inhibited cell growth and lung metastasis in mice. A. Images represent the tumor growth in the nude
mice 24 days after they were injected with 2 × 104 CD117+CD44+-shHOTAIR or CD117+CD44+-scramble. B. Tumor-free mice throughout the 64-day
observation period. C. Tumor sizes dissected from the SKOV3 tumor bearing mice 64 days after the mice were injected with the 2 × 104 CD117+CD44
+-shHOTAIR or CD117+CD44+-scramble cells. D. Tumor volume in a set of 6 mice. E. Presence of tumor cell metastasis in lungs is visible in the CD117
+CD44+-scramble lung tissue section (left); no tumor cells are found in the lungs of the nude mice injected with the CD117+CD44+-shHOTAIR lung
tissue section (right). The sections were stained by H.E. Scale bars: 100 μm (magnification ×200). **P <0.01, referring to the differences as indicated.
Wang et al. Cancer Cell International  (2015) 15:24 Page 8 of 10+CD44+-shHOTAIR markedly reduced cellular metastasis
and invation in vitro as well as the tumorgeniesis in mice.
This efficacy in CD117+CD44+-shHOTAIR was refelected
in a lower clonogenic potential, a lower metastatic and in-
vasive potential, and a weeker ability to form tumors in
the xenografted mice than in CD138−CD34−-scramble.
Importantly, the tumor cell lung metastasis was inhibited
in the mice injected with CD117+CD44+-shHOTAIR,
whereas the metastatic tumor cells were found in the
lungs of the mice injected with CD117+CD44+-scramble.
The evident inhibitory activities in the SKOV3 cells
transfected with siHOTAIR were apparently associated
with inhibited the HOTAIR expression, which resultedin the increase of the epithelium feature molecule of the
E-cadherin expression and reduced mesenchymal feature
molecule of the Vimentin expression. The knockdown of
the HOTAIR expression in CD117+CD44+CSCs may in-
volve the inhibition of EMT of CD117+CD44+CSCs and
the reduction of cellular migration and invasion potential
and tumorgeniesis ability in vitro and in vivo. Neverthe-
less, the knockdown of the HOTAIR expression mechan-
ism in inhibiting the metastasis of the SKOV3 cells and
CD117+CD44+CSCs warrants further investigation.
In conclusion, the above-mentioned finding from our
study is the first proof for demonstrating the novel role of
the dawn-regulated HOTAIR in EOC SKOV3 CD117+
Wang et al. Cancer Cell International  (2015) 15:24 Page 9 of 10CD44+CSCs, for suggesting the inhibitory cellular EMT,
and for decreasing decreased the migration and and
tumorgeniesis potential of CD117+CD44+CSCs. HOTAIR
can be a potential therapeutic target for treatment of EOC
patients.
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